These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 15499141)
1. High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Steer P; Flenady V; Shearman A; Charles B; Gray PH; Henderson-Smart D; Bury G; Fraser S; Hegarty J; Rogers Y; Reid S; Horton L; Charlton M; Jacklin R; Walsh A; Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F499-503. PubMed ID: 15499141 [TBL] [Abstract][Full Text] [Related]
2. Periextubation caffeine in preterm neonates: a randomized dose response trial. Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204 [TBL] [Abstract][Full Text] [Related]
3. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724 [TBL] [Abstract][Full Text] [Related]
4. Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour. Gray PH; Flenady VJ; Charles BG; Steer PA; J Paediatr Child Health; 2011 Apr; 47(4):167-72. PubMed ID: 21244548 [TBL] [Abstract][Full Text] [Related]
5. Early Caffeine and Weaning from Mechanical Ventilation in Preterm Infants: A Randomized, Placebo-Controlled Trial. Amaro CM; Bello JA; Jain D; Ramnath A; D'Ugard C; Vanbuskirk S; Bancalari E; Claure N J Pediatr; 2018 May; 196():52-57. PubMed ID: 29519541 [TBL] [Abstract][Full Text] [Related]
6. Caffeine citrate maintenance doses effect on extubation and apnea postventilation in preterm infants. Wan L; Huang L; Chen P Pediatr Pulmonol; 2020 Oct; 55(10):2635-2640. PubMed ID: 32639634 [TBL] [Abstract][Full Text] [Related]
7. Association of Caffeine Daily Dose With Respiratory Outcomes in Preterm Neonates: A Retrospective Cohort Study. Rauf S; Shah S; Bibi Z; Munir R; Jiskani H; Ahmad S; Mir Shah SA; Bibi A; Fasih Ahmad H; Hussain K; Ariff S; Ambreen G Inquiry; 2024; 61():469580241248098. PubMed ID: 38666733 [TBL] [Abstract][Full Text] [Related]
9. Electrical activity of the diaphragm following a loading dose of caffeine citrate in ventilated preterm infants. Williams EE; Hunt KA; Jeyakara J; Subba-Rao R; Dassios T; Greenough A Pediatr Res; 2020 Mar; 87(4):740-744. PubMed ID: 31622975 [TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled, blinded trial of doxapram for extubation of the very low birthweight infant. Barrington KJ; Muttitt SC Acta Paediatr; 1998 Feb; 87(2):191-4. PubMed ID: 9512207 [TBL] [Abstract][Full Text] [Related]
11. Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates. Yu T; Balch AH; Ward RM; Korgenski EK; Sherwin CM BMC Pharmacol Toxicol; 2016 Jun; 17(1):22. PubMed ID: 27266401 [TBL] [Abstract][Full Text] [Related]
12. [Factors related to extubation failure in premature infants less than 32 weeks of gestation]. Deguines C; Bach V; Tourneux P Arch Pediatr; 2009 Sep; 16(9):1219-24. PubMed ID: 19577908 [TBL] [Abstract][Full Text] [Related]
13. Caffeine to prevent intermittent hypoxaemia in late preterm infants: randomised controlled dosage trial. Oliphant EA; McKinlay CJ; McNamara D; Cavadino A; Alsweiler JM Arch Dis Child Fetal Neonatal Ed; 2023 Mar; 108(2):106-113. PubMed ID: 36038256 [TBL] [Abstract][Full Text] [Related]
14. Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study. Huon C; Rey E; Mussat P; Parat S; Moriette G Acta Paediatr; 1998 Nov; 87(11):1180-4. PubMed ID: 9846921 [TBL] [Abstract][Full Text] [Related]
15. [Clinical effectiveness of different doses of caffeine for primary apnea in preterm infants]. Zhao Y; Tian X; Liu G Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):33-6. PubMed ID: 26791921 [TBL] [Abstract][Full Text] [Related]
16. Doxapram versus placebo in preterm newborns: a study protocol for an international double blinded multicentre randomized controlled trial (DOXA-trial). Poppe JA; Flint RB; Smits A; Willemsen SP; Storm KK; Nuytemans DH; Onland W; Poley MJ; de Boode WP; Carkeek K; Cassart V; Cornette L; Dijk PH; Hemels MAC; Hermans I; Hütten MC; Kelen D; de Kort EHM; Kroon AA; Lefevere J; Plaskie K; Stewart B; Voeten M; van Weissenbruch MM; Williams O; Zonnenberg IA; Lacaze-Masmonteil T; Pas ABT; Reiss IKM; van Kaam AH; Allegaert K; Hutten GJ; Simons SHP Trials; 2023 Oct; 24(1):656. PubMed ID: 37817255 [TBL] [Abstract][Full Text] [Related]
17. Effect of different maintenance doses of caffeine citrate on ventilator weaning in very preterm infants with respiratory distress syndrome: a prospective randomized controlled trial. Li XL; Cai YJ; Zhang Z; Li J; Chen XW; Song YY; Zhou W Zhongguo Dang Dai Er Ke Za Zhi; 2021 Nov; 23(11):1097-1102. PubMed ID: 34753540 [TBL] [Abstract][Full Text] [Related]
18. Safety profile comparison between extemporaneous and a licensed preparation of caffeine citrate in preterm infants with apnea of prematurity. Vatlach S; Arand J; Engel C; Poets CF Neonatology; 2014; 105(2):108-11. PubMed ID: 24335098 [TBL] [Abstract][Full Text] [Related]
19. Association between caffeine citrate exposure and necrotizing enterocolitis in preterm infants. Lampkin SJ; Turner AM; Lakshminrusimha S; Mathew B; Brown J; Fominaya CE; Johnson KK Am J Health Syst Pharm; 2013 Apr; 70(7):603-8. PubMed ID: 23515513 [TBL] [Abstract][Full Text] [Related]
20. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Erenberg A; Leff RD; Haack DG; Mosdell KW; Hicks GM; Wynne BA Pharmacotherapy; 2000 Jun; 20(6):644-52. PubMed ID: 10853619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]